New FDA Guidance Looks to Improve Clinical Trial Enrollment and Diversity
April 30, 2024 9:00 amby Sabrina Serani
The FDA announced new guidance to expand eligibility criteria with the goal of improving participation and diversity in oncology clinical trials.These 3 areas of change include laboratory values, washout periods, and performance status.
While the FDA notes … Read more